The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Payne, K. J.
Right arrow Articles by Crooks, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Payne, K. J.
Right arrow Articles by Crooks, G. M.
The Journal of Immunology, 2001, 167: 1867-1870.
Copyright © 2001 by The American Association of Immunologists


Cutting Edge

Cutting Edge: Predominant Expression of a Novel Ikaros Isoform in Normal Human Hemopoiesis1

Kimberly J. Payne2,*, Jan-Holly Nicolas{dagger}, Judy Y. Zhu*, Lora W. Barsky* and Gay M. Crooks*

* Division of Research Immunology/Bone Marrow Transplantation, Childrens Hospital, Los Angeles, CA 90027; and {dagger} Department of Chemistry and Biochemistry, La Sierra University, Riverside, CA 92515

Murine studies implicate Ikaros proteins as regulators of hemopoiesis, particularly in the lymphoid lineages. High homology between murine and human Ikaros suggests that Ikaros expression in the two might be similar. However, initial human studies that focused on leukemia detected novel Ikaros transcripts in patient samples. Thus, novel Ikaros splice forms and DNA nonbinding isoforms were linked with malignancy. We undertook an extensive analysis of normal human Ikaros expression to determine whether novel mRNAs are expressed as proteins and the extent to which these splice variants are unique to leukemia. Here we show that both mRNA and protein for DNA nonbinding Ikaros isoforms and splice variants previously linked to leukemia are expressed in normal human cells. However, our studies identify a new Ikaros isoform not previously described in mouse or human. This isoform is the predominant Ikaros protein in normal human cells, but not in leukemia cell lines.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
R. Caballero, F. Setien, L. Lopez-Serra, M. Boix-Chornet, M. F. Fraga, S. Ropero, D. Megias, M. Alaminos, E. M. Sanchez-Tapia, M. C. Montoya, et al.
Combinatorial effects of splice variants modulate function of Aiolos
J. Cell Sci., August 1, 2007; 120(15): 2619 - 2630.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ronni, K. J. Payne, S. Ho, M. N. Bradley, G. Dorsam, and S. Dovat
Human Ikaros Function in Activated T Cells Is Regulated by Coordinated Expression of Its Largest Isoforms
J. Biol. Chem., January 26, 2007; 282(4): 2538 - 2547.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
E. Yamamoto, T. Ito, A. Abe, F. Sido, K. Ino, A. Itakura, S. Mizutani, S. Dovat, S. Nomura, and F. Kikkawa
Ikaros is expressed in human extravillous trophoblasts and involved in their migration and invasion
Mol. Hum. Reprod., November 1, 2005; 11(11): 825 - 831.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. J. Payne, G. Huang, E. Sahakian, J. Y. Zhu, N. S. Barteneva, L. W. Barsky, M. A. Payne, and G. M. Crooks
Ikaros Isoform X Is Selectively Expressed in Myeloid Differentiation
J. Immunol., March 15, 2003; 170(6): 3091 - 3098.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Ishimaru, T. Yagi, S. Hibi, M. Takanashi, G. Kano, Y. Tabata, T. Imamura, T. Inaba, A. Morimoto, S. Todo, et al.
Expression of Ikaros isoforms in patients with acute myeloid leukemia
Blood, July 30, 2002; 100(4): 1511 - 1513.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.